Dengue vaccination strategy for children in the French Caribbean
Official title: Preparing for the Use of a Dengue Vaccine in the French Caribbean Islands of Martinique and Guadeloupe : the DengueSEA Study
Run by University Hospital Center of Martinique · NCT04839757 · Data updated 2026-11-12
This study is trying to see how many children in Martinique and Guadeloupe have been exposed to dengue and whether parents are open to giving them the Dengvaxia® vaccine.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 9 Years to 17 Years |
| Sex | All |
| Enrollment | 590 (estimated) |
| Sponsor | University Hospital Center of Martinique Academic / other |
| Locations | 1 site (Fort-de-France) |
| Status | Recruiting |
| Started | June 3, 2021 |
| Main results expected | December 2025 |
| Study ends | February 2026 |
| Registry record updated | February 21, 2025 |
| Trial ID | NCT04839757 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 9 to 17 years residing in Martinique or Guadeloupe.
✕Probably not a fit
Patients with acute infections or immune deficiencies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather seroprevalence data on dengue among children aged 9 to 17 years in Martinique and Guadeloupe, regions significantly affected by dengue outbreaks. It will assess the acceptability of the Dengvaxia® vaccine among parents and guardians, exploring factors contributing to vaccine hesitancy. The study will involve blood sampling for serological testing and surveys to understand parental attitudes towards vaccination. The findings will inform optimal vaccine introduction strategies in these endemic areas.
Why it matters
Potential benefit: If successful, this study could enhance vaccination strategies and improve dengue prevention in children in endemic regions.
How similar studies have gone: While similar studies have been conducted in adults, this specific focus on children in the French Caribbean is novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
CHILDREN
Inclusion Criteria for children:
* Any child aged 9 to 17 years presenting to one of the hospital departments participating in the study at the University Hospitals of Martinique or Guadeloupe
* Need to take a blood sample or place a peripheral venous line for the management of the child
* Residence in Martinique or Guadeloupe since at least one year
* Information on the study given to the child and his/her parent or legal guardian
* Collection of the parent's or legal guardian's non-objection to the child's participation
Exclusion Criteria for children:
* Presence of fever or suspected acute infection
* Presence of an immune deficiency or any other dysimmune condition
PARENTS
Parental inclusion criteria ("vaccine acceptability" survey)
* Collection of the parent's or legal guardian's non-objection to participate in the Dengvaxia® vaccine acceptability survey
* Comprehension of spoken and written French
Non-inclusion criteria for parents (vaccine acceptability survey)
\- None of the above
Where it's running
-
Martinique University Hospital Center
Fort-de-France, Martinique Recruiting
Study contacts
- Principal investigator: Andre CABIE — Martinique University Hospital Center
- Study coordinator: Véronique PELONDE-ERIMEE
- Email: veronique.pelonde-erimee@chu-martinique.fr
- Phone: 0596592697
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Survey to assess eligibility for infectious disease clinical trials
This study is trying to find out if people are eligible to join clinical trials for infectious diseases like HIV and vaccines by having them fill out a survey about their health and background.
-
RSV vaccine safety and immune response in lung transplant patients vs. healthy adults
This study tests how well the RSV vaccine works and how safe it is in people who have had a lung transplant compared with healthy adults.
-
Dengue virus challenge in healthy adults to study immune responses
Researchers will infect healthy adults with a weakened dengue virus to see how their bodies respond and how past exposure affects the reaction.
-
Sleep and Teens’ Immune Response to a Meningococcal Vaccine
This study checks if 11- to 12-year-olds’ sleep habits affect how well their vaccine for meningococcal disease works.
-
Gut leakage in dengue: is the intestinal barrier affected during infection?
Researchers are studying whether dengue infection disrupts the gut barrier and if that contributes to severe disease in adults with dengue who are in hospital.
-
OptiMAx: testing SQ-LNS to boost vaccination in rural Chad and Niger
This study tests whether giving small-batch SQ-LNS to young children helps increase routine immunizations in rural Chad and Niger.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.